This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovator Jeon Hyun Suk: Pioneering Anti-Inflammatory Solutions
Introduction
Jeon Hyun Suk is an accomplished inventor based in Gwangju, South Korea. He is recognized for his contributions to the field of medicinal chemistry, particularly through his innovative approaches to anti-inflammatory treatments.
Latest Patents
Jeon holds a patent titled "6-Alkylamino-2-methyl-2'-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative as anti-inflammatory inhibitor." This invention details a novel compound that demonstrates a significant inhibitory effect on 5-lipoxygenase (5-LO) activity, making it a promising candidate in the prevention and treatment of leukotriene activation-related diseases such as rheumatoid arthritis, colitis, asthma, and psoriasis. The patent also outlines an efficient method for synthesizing this compound using a parallel synthetic approach, which is part of combinatorial chemical synthetic techniques.
Career Highlights
Jeon Hyun Suk has made notable strides in his career and is affiliated with the Korea Research Institute of Chemical Technology. His work focuses on developing innovative solutions that aim to address prevalent health issues related to inflammation. With a solid understanding of chemical technology, he has made invaluable contributions to the field.
Collaborations
Throughout his career, Jeon has collaborated with esteemed colleagues such as Young-Dae Gong and Hyae-Gyeong Cheon. These partnerships have fostered a collaborative research environment, leading to advancements in their respective fields and enhancing the impact of their innovations.
Conclusion
Jeon Hyun Suk exemplifies the spirit of innovation through his groundbreaking work and dedication to improving health outcomes. His patent on an anti-inflammatory compound stands as a testament to his expertise and commitment to advancing medicinal chemistry. As research continues to evolve, Jeon's contributions will undoubtedly play a crucial role in addressing inflammatory diseases and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile